Search

everythinglearnresearchcommunity

for

Search:↓

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Skin reactions from cancer treatments might predict how well the treatments work.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Cetuximab can cause excessive eyelash growth.

Targeting colon cancer stem cells might lead to better treatment results.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Reducing reactive oxygen species can help treat nerve damage from platinum cancer drugs.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

p14ARF and p16Ink4a cause hair follicle stem cell aging and dysfunction.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.